Comparing Bosutinib Versus Imatinib in Newly Diagnosed CML Targeted Oncology 2:53 7 years ago 1 094 Скачать Далее
5-year update of BFORE: bosutinib vs imatinib in CML VJHemOnc – Video Journal of Hematology & HemOnc 2:12 1 year ago 354 Скачать Далее
Bosutinib versus imatinib for newly diagnosed chronic phase CML: Bfore trial final 5-year results ecancer 7:53 3 years ago 353 Скачать Далее
Bosutinib Versus Imatinib for Newly Diagnosed CML: Initial Results from the BFORE Trial Oncology.TV 7:47 7 years ago 598 Скачать Далее
Final results of the BFORE trial: bosutinib vs imatinib in CP-CML VJHemOnc – Video Journal of Hematology & HemOnc 1:10 1 year ago 306 Скачать Далее
Five-year follow-up data from the BFORE trial: bosutinib versus imatinib in CML VJHemOnc – Video Journal of Hematology & HemOnc 1:54 1 year ago 223 Скачать Далее
Epic:Phase 3 Trial of Ponatinib Compared with Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Oncology.TV 2:50 9 years ago 525 Скачать Далее
Bosutinib Versus Imatinib (CML) Follow Up Study - Carlo Gambacorti-Passerini, MD Oncology.TV 5:22 12 years ago 1 758 Скачать Далее
Bosutinib in newly diagnosed CML: GI, liver, effusion, and renal safety characterization VJHemOnc – Video Journal of Hematology & HemOnc 2:32 2 years ago 247 Скачать Далее
BELA Trial: Bosutinib May Be Superior to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid L Chris Bubeck 4:54 12 years ago 159 Скачать Далее
Tolerability of bosutinib vs asciminib in heavily pre-treated patients with CML VJHemOnc – Video Journal of Hematology & HemOnc 1:10 1 year ago 154 Скачать Далее
Andreas Hochhaus: Asciminib vs. Bosutinib in Chronic Myeloid Leukemia American Society of Hematology 5:37 3 years ago 1 204 Скачать Далее
BELA Trial: Bosutinib May Be Superior to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid L Chris Bubeck 3:20 12 years ago 107 Скачать Далее
Comparing Frontline Therapies for the Treatment of Chronic Myeloid Leukemia Targeted Oncology 1:59 4 years ago 200 Скачать Далее
Asciminib and bosutinib efficacy in CML-CP patients: a comparison study VJHemOnc – Video Journal of Hematology & HemOnc 3:28 3 years ago 494 Скачать Далее
Nilotinib Versus Imatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive CML-CP Oncology.TV 4:47 12 years ago 2 558 Скачать Далее
Dr. Timothy Hughes Compares Imatinib to Nilotinib in Chronic Myeloid Leukemia OncLive 1:40 11 years ago 1 522 Скачать Далее
Bosutinib: a new, safer TKI for frontline CML VJHemOnc – Video Journal of Hematology & HemOnc 1:03 5 years ago 958 Скачать Далее
